4i0g Citations

Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.

Bioorg Med Chem Lett 23 2181-6 (2013)
Related entries: 4hzt, 4i0z, 4i10, 4i11

Cited: 5 times
EuropePMC logo PMID: 23465612

Abstract

The structure-activity relationship of a series of dihydroisoquinoline BACE-1 inhibitors is described. Application of structure-based design to screening hit 1 yielded sub-micromolar inhibitors. Replacement of the carboxylic acid of 1 was guided by X-ray crystallography, which allowed the replacement of a key water-mediated hydrogen bond. This work culminated in compounds such as 31, which possess good BACE-1 potency, excellent permeability and a low P-gp efflux ratio.

Articles citing this publication (5)

  1. Biological and computational evaluation of resveratrol inhibitors against Alzheimer's disease. Koukoulitsa C, Villalonga-Barber C, Csonka R, Alexi X, Leonis G, Dellis D, Hamelink E, Belda O, Steele BR, Micha-Screttas M, Alexis MN, Papadopoulos MG, Mavromoustakos T. J Enzyme Inhib Med Chem 31 67-77 (2016)
  2. Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors. Mondal K, Regnstrom K, Morishige W, Barbour R, Probst G, Xu YZ, Artis DR, Yao N, Beroza P, Bova MP. Biochem. Biophys. Res. Commun. 441 291-296 (2013)
  3. One-pot synthesis of 1H-isochromenes and 1,2-dihydroisoquinolines by a sequential isocyanide-based multicomponent/Wittig reaction. Wang L, Guan ZR, Ding MW. Org. Biomol. Chem. 14 2413-2420 (2016)
  4. Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening Approaches. Rombouts FJR, Alexander R, Cleiren E, De Groot A, Carpentier M, Dijkmans J, Fierens K, Masure S, Moechars D, Palomino-Schätzlein M, Pineda-Lucena A, Trabanco AA, Van Glabbeek D, Vos A, Tresadern G. ACS Omega 2 685-697 (2017)
  5. Access to 1-amino-3,4-dihydroisoquinolines via palladium-catalyzed C-H bond aminoimidoylation reaction from functionalized isocyanides. Xiong Z, Cai P, Mei Y, Wang J. RSC Adv 9 42072-42076 (2019)